Risperidone Drugs BNFC

At typical clinical doses, risperidone was found to occupy 65% to 69% of D2 receptors 12 to 14 hours after the last dose; a mean occupancy of 79% was found in

Abstract Once administered, risperidone is converted into its pharmacologically active form, paliperidone Thus, their pharmacological effects are expected to

risperidone Risperidone Tablets are indicated for the short-term treatment of persistent aggression in patients with moderate to severe Alzheimer's dementia

risperidone Risperidone Risperidone is a member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyridopyrimidin-4-one carrying an additional 2